You are Here: Drug Litigation > Pradaxa

Pradaxa: A Brief Overview:

For those patients with heart valve problems or atrial fibrillation who are at a significantly elevated risk of stroke, the drug Pradaxa (Dabigatran), approved by the FDA merely twenty-eight months ago appeared to be a good solution to these medical issues. Pradaxa (Dabigatran) falls under a group of drugs known as direct thrombonin inhibitors which work by limiting the actions of a specific blood enzyme which is crucial to the blood clotting process. Pradaxa (Dabigatran) is indicated for use as an anti-coagulant, along the lines of the drug Warfarin, although the makers of Pradaxa (Dabigatran), Boehringer Ingelhem, claim their drug is at least 35% more effective in reducing the risk of stroke than Warfarin. Since the kidneys are responsible for expelling Pradaxa (Dabigatran) from the body, increased quantities of the drug can remain in the body when kidney function is not optimal, leading to potential bleeding problems.


Pradaxa: A Brief Overview:

For those patients with heart valve problems or atrial fibrillation who are at a significantly elevated risk of stroke, the drug Pradaxa (Dabigatran), approved by the FDA merely twenty-eight months ago appeared to be a good solution to these medical issues. Pradaxa (Dabigatran) falls under a group..... More...

Pradaxa: The FDA’s Stance:

Pradaxa (Dabigatran) is a blood-thinning drug which is prescribed to reduce the elevated risk of stroke among patients who suffer from heart valve problems or atrial fibrillation. Pradaxa (Dabigatran) is the first drug in its class to gain FDA approval in nearly sixty years, since the drug Warfarin—also known.... More...

The Dangers of Pradaxa: Cerebral Hemorrhage, Internal Bleeding, and Death.

Pradaxa (Dabigatran) is the “new kid on the block” prescription drug used in the treatment of heart valve problems or atrial fibrillation in those who have an elevated risk of stroke. Pradaxa (Dabigatran) was given the FDA green light.... More...

Pradaxa Lawsuits: Do I Have a Case?

While Pradaxa (Dabigatran) did not gain U.S. FDA approval until October of 2010, it became the subject of a New Zealand investigation in September, 2011, after five elderly patients died from severe internal bleeding. The relatives of those patients noted that adverse side effects began when their loved ones.... More...

How We Can Help:

If you have been the victim of a drug which caused death or serious harm to you or a loved one you may be confused about whether you need the services of a personal injury attorney. You want the best outcome possible for adverse health events caused by drugs such as Pradaxa (Dabigatran).... More...


Free Consultation  Call Now

Get Interactive

Sullo & Sullo-Facebook Sullo & Sullo-Linkedin Sullo & Sullo-Twitter Sullo & Sullo-You Tube
 
Free Consultation
Receive an immediate response to your request.
Choose the Practice Area of Your Problem:

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. I further understand and agree to the Terms of Use and Privacy Policy

CAPTCHA image
Enter the code shown above in the box below

Recent Articles & Publications

June 19, 2012
This article will continue the discussion held by a group of attorneys during a recent Pradaxa litigation seminar. The discussion centered primarily around venue although...

June 17, 2012
Continuing from Part One of the Pradaxa Lawsuit articles, we continue with the discussion held by attorneys who are interested in Pradaxa litigation and the issues they found...

June 15, 2012
A group of attorneys interested in the Pradaxa litigation assembled to discuss the issue in a recent seminar. Pradaxa is a drug prescribed primarily for atrial fibrillation,...